142 related articles for article (PubMed ID: 9351772)
1. Cost-effectiveness of fetal lung maturity testing in preterm labor.
Myers ER; Alvarez JG; Richardson DK; Ludmir J
Obstet Gynecol; 1997 Nov; 90(5):824-9. PubMed ID: 9351772
[TBL] [Abstract][Full Text] [Related]
2. Changes in the threshold of fetal lung maturity testing and neonatal outcome of infants delivered electively before 39 weeks gestation: implications and cost-effectiveness.
Ventolini G; Neiger R; Hood DL; Belcastro MR
J Perinatol; 2006 May; 26(5):264-7. PubMed ID: 16598293
[TBL] [Abstract][Full Text] [Related]
3. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks].
Kinalski M; Sledziewski A; Kretowski A
Wiad Lek; 2000; 53(9-10):538-45. PubMed ID: 11148922
[TBL] [Abstract][Full Text] [Related]
4. Is 34 weeks an acceptable goal for a complicated singleton pregnancy?
Jones JS; Istwan NB; Jacques D; Coleman SK; Stanziano G
Manag Care; 2002 Oct; 11(10):42-7. PubMed ID: 12415908
[TBL] [Abstract][Full Text] [Related]
5. Threatened preterm labor: the influence of time factors on the incidence of respiratory distress syndrome.
Schutte MF; Treffers PE; Koppe JG
Obstet Gynecol; 1983 Sep; 62(3):287-93. PubMed ID: 6877685
[TBL] [Abstract][Full Text] [Related]
6. Willingness or unwillingness to perform cesarean section for impending preterm delivery at 24 weeks' gestation: a cost-effectiveness analysis.
Cazan-London G; Mozurkewich EL; Xu X; Ransom SB
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1187-92. PubMed ID: 16157135
[TBL] [Abstract][Full Text] [Related]
7. [Lung maturation therapy with glucocorticoids in threatened premature labor. Considerations of risk-benefit in evidence-based medicine].
Sauerwald A; Rath W
Z Geburtshilfe Neonatol; 2000; 204(6):203-9. PubMed ID: 11199148
[TBL] [Abstract][Full Text] [Related]
8. Aminophylline treatment of preterm labor.
Melis GB; Fruzzetti F; Strigini F; Barale E; Capriello P; Baisi F; Cipolloni C; Fioretti P
Acta Eur Fertil; 1984; 15(5):357-61. PubMed ID: 6528793
[TBL] [Abstract][Full Text] [Related]
9. Requirements of perinatal prevention and treatment of respiratory distress syndrome.
Di Renzo GC; Anceschi MM; Guidetti R; Cosmi EV
Eur Respir J Suppl; 1989 Mar; 3():68s-72s. PubMed ID: 2662998
[TBL] [Abstract][Full Text] [Related]
10. [Premature labor, determination of fetal lung maturity and medicamentous induction of lung maturation].
Baumann P; Diedrich K
Z Geburtshilfe Neonatol; 1997; 201 Suppl 1():63-7. PubMed ID: 9410531
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of selected methods for intrauterine stimulation of fetal pulmonary maturation].
Sledziewski A; Kinalski M; Kretowski A
Przegl Lek; 2000; 57(3):171-7. PubMed ID: 10909290
[TBL] [Abstract][Full Text] [Related]
12. [Induction of fetal lung maturity with combined hormonal therapy in premature labor].
Serman F; Pazols R; Benavides C; Sandoval J; Ferres I; Lamoza P
Rev Chil Obstet Ginecol; 1994; 59(1):44-8. PubMed ID: 7809432
[TBL] [Abstract][Full Text] [Related]
13. [Long-term tocolysis in premature rupture of the fetal membranes and premature labor].
Spitzer D; Haidbauer R; Staudach A
Gynakol Rundsch; 1989; 29 Suppl 2():191-4. PubMed ID: 2613014
[No Abstract] [Full Text] [Related]
14. [Dilemmas about the antenatal use of corticosteroids for prevention of neonatal morbidity and mortality].
Grgić O; Matijević R
Acta Med Croatica; 2005; 59(2):129-35. PubMed ID: 15909887
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis.
Stevens TP; Sinkin RA; Hall CB; Maniscalco WM; McConnochie KM
Arch Pediatr Adolesc Med; 2000 Jan; 154(1):55-61. PubMed ID: 10632251
[TBL] [Abstract][Full Text] [Related]
16. [Value of fetal lung maturity assessment in maternal diabetes].
Beinlich A; Fischäss C; Kaufmann M; Schlösser R; Dericks-Tan JS
Zentralbl Gynakol; 1999; 121(10):484-7. PubMed ID: 10573822
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of surface tension with determination of the L/S ratio in amniotic fluid for prediction of fetal lung maturity].
Joura EA; Kainz C; Joura EM; Böhm R; Gruber W; Gitsch G
Z Geburtshilfe Neonatol; 1995; 199(2):78-80. PubMed ID: 7788582
[TBL] [Abstract][Full Text] [Related]
18. Lung maturational agents and surfactant treatments: are they complementary in preterm infants?
Jobe AH
J Perinatol; 1989 Mar; 9(1):14-8. PubMed ID: 2709148
[TBL] [Abstract][Full Text] [Related]
19. [Tocolysis: which are the benefits?].
Di Renzo GC; Donati Sarti R; Gori F; Gerli S
Minerva Ginecol; 2006 Dec; 58(6):479-87. PubMed ID: 17108878
[TBL] [Abstract][Full Text] [Related]
20. Lamellar body count in amniotic fluid as a rapid screening test for fetal lung maturity.
Lee IS; Cho YK; Kim A; Min WK; Kim KS; Mok JE
J Perinatol; 1996; 16(3 Pt 1):176-80. PubMed ID: 8817425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
